Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate.
about
sameAs
Systemic antibiotics for treating diabetic foot infectionsTreatment of Gram-positive infections in critically ill patientsCo-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infectionsSystemic antibiotic therapy for chronic osteomyelitis in adultsA review of linezolid: the first oxazolidinone antibiotic.Efficacy and tolerability of linezolid in chronic osteomyelitis and prosthetic joint infections: a case-control study.Diagnosis and treatment of diabetic foot infections.A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.New insights in diabetic foot infectionLinezolid for the treatment of drug-resistant infections.Zinc-triggered hydrogelation of self-assembled small molecules to inhibit bacterial growth.The interventional therapy for diabetic peripheral artery disease.Methicillin-resistant Staphylococcus aureus in HIV-infected patients.Carbon nanotubes as in vivo bacterial probesA randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infectionsPET imaging of bacterial infections with fluorine-18-labeled maltohexaose.The safety and efficacy of linezolid in orthopaedic practice for the treatment of infection due to antibiotic-resistant organisms.Complicated skin, skin structure and soft tissue infections - are we threatened by multi-resistant pathogens?Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycinA review of the microbiology, antibiotic usage and resistance in chronic skin wounds.Antimicrobial interventions for the management of diabetic foot infections.Role of linezolid in the treatment of orthopedic infections.Infection in the neuroischemic foot.Update on linezolid: the first oxazolidinone antibiotic.Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.Systematic review of antimicrobial treatments for diabetic foot ulcers.Diabetic foot infections: stepwise medical and surgical management.Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study.Clinical management of diabetic foot infection: diagnostics, therapeutics and the future.Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions.Linezolid: effectiveness and safety for approved and off-label indications.Update on the appropriate use of linezolid in clinical practiceThe treatment of diabetic foot infections: focus on ertapenem.Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?Pharmacotherapy of diabetic foot osteomyelitis.Complicated skin and soft tissue infection.Current medical management of diabetic foot infections.Osteomyelitis: an update for hospitalists.
P2860
Q24187313-6973F7D1-57AF-4E91-9D20-4CAD3C9396E8Q27015976-87FCD298-854B-4BC3-9300-765619CBDEBAQ27015976-CC457F1D-B0FB-4339-BECB-27EE15BF51ECQ28394377-2340C517-E984-44AC-BCE5-70871830BA46Q28394377-A787AE80-2137-4113-A5A0-EF4AFD9E0CF7Q28714211-99805825-032D-4188-A353-F198566603EFQ28714211-B8F90A1C-CF3A-4B06-9FAF-9350F30AB12DQ33363226-C7001D61-5BAA-4BAE-BF6B-9B99549D1520Q33384409-E4CBD637-F43A-48A8-9C78-93AC65E4C4C5Q34357233-659F282D-1CA3-4777-BFA5-41A5F88215D7Q34420942-9446EE25-361E-43BD-932C-0768DE54F46BQ34420942-B3781643-9E61-4561-9BF3-C1004692F8A6Q34478074-4A97C538-5185-4DC4-BFA7-920C3FDFE03FQ34478074-A49B769A-DE18-404F-BF37-EB33E94E8C9CQ34878021-A1C5D100-9A33-4970-AA83-53E1A9D85167Q34878021-A389D751-C262-4877-8610-7DB4BC50A831Q34894133-01751A66-C6DE-48E4-9C63-E30F4FDB7A3CQ34925381-0E4AB6C9-4374-4A2E-9216-0203DB54CED5Q34925381-FE1F0D73-8774-4DEF-93FA-310263491EF3Q34956122-19CEC24E-E390-49BF-AC44-688B607F3810Q34956122-3AD5DA9F-6820-42C1-B327-B2C55D2D0AA0Q35026548-CB09AB5F-D3C2-4EDE-B043-834CAFDB1797Q35026548-D791F14B-A022-4287-91F1-81105141B07FQ35146707-CBCBC4E5-3F4E-4742-8E66-A23AEC698103Q35146707-F2C53AAB-C82F-487D-A783-FE745EDE4606Q35328383-149A191E-C16A-4058-9F02-11DEC94152A3Q35328383-4A798B08-09DF-4224-970E-7411FCC2FF2CQ35602940-0281423D-8099-4ADF-A614-5889D1F66A10Q35602940-56092912-68BE-4A65-983D-27D996F42141Q35873712-715EF074-D189-41F9-97C6-0647F21656AFQ35959551-7F003D37-13DD-4B24-83FE-47ABA76A37D0Q35959551-B44AA320-218F-4DBA-80F3-A1A8DECBF455Q35959558-F2011915-A63E-452C-A3C8-95C6070A576CQ35959558-FD9C4385-472C-44C0-A030-29C064F3FEC2Q36009107-DFD82A31-F2ED-40CD-9D28-7EC78423A0CBQ36066093-9A20479F-D681-4FE0-88C8-99AE1F872958Q36162348-71490343-D1FF-4740-A884-334D54FFF836Q36229278-F098D58A-9087-40B9-9CF5-04B37BD4E5F3Q36283744-031F350E-9928-4609-8F25-D4D4C933D887Q36409465-1168D917-0A5B-4092-8D1C-4C7AE963FE31
P2860
Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Treating foot infections in di ...... actam/amoxicillin-clavulanate.
@ast
Treating foot infections in di ...... actam/amoxicillin-clavulanate.
@en
Treating foot infections in di ...... actam/amoxicillin-clavulanate.
@nl
type
label
Treating foot infections in di ...... actam/amoxicillin-clavulanate.
@ast
Treating foot infections in di ...... actam/amoxicillin-clavulanate.
@en
Treating foot infections in di ...... actam/amoxicillin-clavulanate.
@nl
altLabel
Treating Foot Infections in Di ...... bactam/Amoxicillin‐Clavulanate
@en
Treating Foot Infections in Di ...... bactam/Amoxicillin‐Clavulanate
@nl
prefLabel
Treating foot infections in di ...... actam/amoxicillin-clavulanate.
@ast
Treating foot infections in di ...... actam/amoxicillin-clavulanate.
@en
Treating foot infections in di ...... actam/amoxicillin-clavulanate.
@nl
P2093
P2860
P1476
Treating Foot Infections in Di ...... bactam/Amoxicillin‐Clavulanate
@en
Treating foot infections in di ...... actam/amoxicillin-clavulanate.
@en
P2093
Benjamin A Lipsky
Carl Norden
Kamal Itani
Linezolid Diabetic Foot Infections Study Group
P2860
P356
10.1002/CNE.99
10.1086/380449
P407
P577
2003-12-09T00:00:00Z
2004-01-01T00:00:00Z